THE THERAPY OF MYELOMA-A CONCEPTUAL APPROACH.JACOBS P; DUBOVSKY D.1975; CENTR. AFR. J. MED.; RHODEVIA; DA. 1975; VOL. 21; NO 7; PP. 158-160; BIBL. 11 REF.Article

RAPID REMISSION INDUCTION IN ADULT ACUTE NON-LYMPHOBLASTIC LEUKAEMIADUBOVSKY D; KERNOFF L; JACOBS P et al.1978; EUROP. J. CANCER; GBR; DA. 1978; VOL. 14; NO 11; PP. 1179-1183; BIBL. 20 REF.Article

STUDIES ON PLATELETS CONTAINED IN ELUATES FOLLOWING FILTRATION LEUKOPHERESISKERNOFF L; SHACKLETON D; DUBOVSKY D et al.1979; TRANSFUSION; USA; DA. 1979; VOL. 19; NO 2; PP. 114-119; BIBL. 15 REF.Article

BONE MARROW CULTURE IN VITRO. A TECHNIQUE FOR ANALYSIS AND PERMANENT RECORDING OF CELLULAR COMPOSITIONJACOBS P; DUBOVSKY D; SMITH S et al.1979; EXPER. HEMATOL.; DNK; DA. 1979; VOL. 7; NO 4; PP. 177-182; BIBL. 10 REF.Article

Non-myeloablative allogeneic transplantation ('microallograft') for refractory myeloma after two preceding autografts : feasibility and efficacy in a patient with active aspergillosisSINGHAL, S; SAFDAR, A; CHIANG, K. Y et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 11, pp 1231-1233, issn 0268-3369Article

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinomaMOORE, D. F; PAZDUR, R; ABBRUZZESE, J. L et al.Annals of oncology. 1994, Vol 5, Num 3, pp 286-287, issn 0923-7534Article

Phase II evaluation of fluorouracil and recombinant α-2a-interferon in previously untreated patients with pancreatic adenocarcinomaPAZDUR, R; AJANI, J. J; ABBRUZZESE, J. L et al.Cancer. 1992, Vol 70, Num 8, pp 2073-2076, issn 0008-543XArticle